Drugs that contain Amisulpride

1. List of Barhemsys drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9545426 ACACIA Use of amisulpride as an anti-emetic
Mar, 2031

(7 years from now)

US9889118 ACACIA Use of amisulpride as an anti-emetic
Mar, 2031

(7 years from now)

US10525033 ACACIA Use of amisulpride as an anti-emetic
Mar, 2031

(7 years from now)

US9084765 ACACIA Use of amisulpride as an anti-emetic
Feb, 2034

(10 years from now)

US11357753 ACACIA Rescue treatment of post operative nausea and vomiting
Feb, 2038

(14 years from now)

Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Feb 26, 2025

NCE-1 date: 2024-02-27

Market Authorisation Date: 26 February, 2020

Treatment: Prevention of post-operative nausea and vomiting; Treatment of post-operative nausea and vomiting

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

BARHEMSYS family patents

11

United States

4

United Kingdom

4

European Union

3

Israel

3

Denmark

3

Mexico

3

Slovenia

3

Croatia

3

Portugal

3

Cyprus

3

Spain

3

Poland

3

RS

3

Japan

2

Australia

2

Brazil

2

Korea, Republic of

2

San Marino

2

China

EA

2

EA

2

Canada

1

Hong Kong

1

Lithuania

1

Hungary

1

Norway

1

New Zealand

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic